SASKATOON – Teenagers and pet dogs stand to benefit from a novel therapy for bone cancer being developed at the University of Saskatchewan (USask).
Human and veterinary cancer specialists at USask have been awarded $765,000 in federal funding to develop a new treatment for osteosarcoma, a type of bone cancer that particularly affects teenagers and under-25 year olds. It is also a common cause of death in large-breed dogs, such as Newfoundlands.
“In teenagers and young adults, the survival rates have not improved for 25 years. One of our goals is to improve this,” said Ekaterina Dadachova, who holds the Fedoruk Centre for Nuclear Innovation Chair in Radiopharmacy, and is also leading the research along with pathologist Maruti Uppalapati.
